Evidence map›Paper›PMID 42282968›Full record

ArticleFrontiers in immunology2026

Correction: Non-human primate preclinical model revealed the feasibility and short-term safety of iPSC-derived innate-like T cells in autologous transplantation.

Yasuyuki Miyake, Shoichi Iriguchi, Ai Kawana-Tachikawa, Shuichi Kitayama, Eri Imai, Kahoru Taya, Hiroshi Ishii, Tomoyuki Miura, Hiromi Sakawaki, Tetsuro Matano and 1 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Yasuyuki MiyakeShin Kaneko Laboratory, Department of Cell Growth and Differentiation, Center for iPS cell research and application (CiRA), Kyoto University, Kyoto, Japan.
Shoichi IriguchiShin Kaneko Laboratory, Department of Cell Growth and Differentiation, Center for iPS cell research and application (CiRA), Kyoto University, Kyoto, Japan.
Ai Kawana-TachikawaAIDS Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
Shuichi KitayamaShin Kaneko Laboratory, Department of Cell Growth and Differentiation, Center for iPS cell research and application (CiRA), Kyoto University, Kyoto, Japan.
Eri ImaiShin Kaneko Laboratory, Department of Cell Growth and Differentiation, Center for iPS cell research and application (CiRA), Kyoto University, Kyoto, Japan.
Kahoru TayaShin Kaneko Laboratory, Department of Cell Growth and Differentiation, Center for iPS cell research and application (CiRA), Kyoto University, Kyoto, Japan.
Hiroshi IshiiDepartment of Latent Infection, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
Tomoyuki MiuraInstitute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan.
Hiromi SakawakiInstitute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan.
Tetsuro MatanoNational Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
Shin KanekoShin Kaneko Laboratory, Department of Cell Growth and Differentiation, Center for iPS cell research and application (CiRA), Kyoto University, Kyoto, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fimmu.2025.1653275.].

Indexed as

IPSCiPSC-derivediPSC-derived T cell autologous administrationpreclinicalprimate model

Identifiers

PMID42282968
PMCPMC13251692

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.